Impella RP Flex with Smart Assist
ConditionRight Ventricular (RV) Dysfunction
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAbiomed Inc.
About this trial
To capture observational data of the Abiomed Impella RP Flex in a real-world setting.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Subjects who received mechanical circulatory support (MCS) with an Impella RP Flex will be considered eligible for the registry.
Disqualifiers
None
Trial population
This study includes sites from the US
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Right-sided ventricular assist device
DevicePercutaneous device for right heart support
Treatment groups
200 Participants
are divided into 1 treatment groupGroup A: Patients implanted with right-sided ventricular assist device1 intervention
Trial outcomes
Primary outcomes
1
Objectives
Survival at hospital discharge, with follow-ups at 30 days, 90 days, and 1-year post-discharge of Impella RP patients from real-world surveillance data.
Time frame
1 year post implantSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov